Literature DB >> 12079603

Telemedicine versus in-person dermatology referrals: an analysis of case complexity.

Elizabeth Krupinski1, Gail Barker, Gilmer Rodriguez, Michael Engstrom, Norman Levine, Ana Maria Lopez, Ronald S Weinstein.   

Abstract

The goal of this study was to determine whether teledermatology referrals differ significantly from in-person referrals with respect to case complexity and diagnosis of cases referred. Teledermatology cases were compared to in-person cases seen by the same university dermatologist who also reviews the teledermatology cases. These were also compared with in-person cases evaluated by a different dermatologist at local clinics using traditional referral patterns. Study parameters included Current Procedural Terminology (CPT) codes as a measure of case complexity, International Classification of Disease (ICD) codes as a measure of case types, and time from referral to actual consultation. The most common CPT codes used for teledermatology were 99241 and 99242 with no significant differences in the frequency of assigned CPT codes for teledermatology versus in-person consultation. An analysis of the diagnostic codes revealed no significant differences between the types of cases referred to telemedicine and those referred for in-person consultation. Time between referral and actual encounter with the dermatologist was significantly shorter via telemedicine than either local or university clinic in-person visits.

Entities:  

Mesh:

Year:  2002        PMID: 12079603     DOI: 10.1089/15305620260008075

Source DB:  PubMed          Journal:  Telemed J E Health        ISSN: 1530-5627            Impact factor:   3.536


  7 in total

1.  Understanding visual search patterns of dermatologists assessing pigmented skin lesions before and after online training.

Authors:  Elizabeth A Krupinski; Joseph Chao; Rainer Hofmann-Wellenhof; Lynne Morrison; Clara Curiel-Lewandrowski
Journal:  J Digit Imaging       Date:  2014-12       Impact factor: 4.056

2.  Patient-centered online management of psoriasis: a randomized controlled equivalency trial.

Authors:  Cindy J Chambers; Kory K Parsi; Clayton Schupp; April W Armstrong
Journal:  J Am Acad Dermatol       Date:  2011-09-03       Impact factor: 11.527

3.  [Teledermatology versus consultations--a comparative study of 120 consultations].

Authors:  F E Herrmann; K Sönnichsen; A Blum
Journal:  Hautarzt       Date:  2005-10       Impact factor: 0.751

Review 4.  Overview of international teledermatology.

Authors:  Brijal Desai; Karen McKoy; Carrie Kovarik
Journal:  Pan Afr Med J       Date:  2010-07-20

5.  Access to Dermatological Care with an Innovative Online Model for Psoriasis Management: Results from a Randomized Controlled Trial.

Authors:  Adam R Ford; Caitlin M Gibbons; Josefina Torres; Heather A Kornmehl; Sanminder Singh; Paulina M Young; Cindy J Chambers; Emanual Maverakis; Cory A Dunnick; April W Armstrong
Journal:  Telemed J E Health       Date:  2018-09-14       Impact factor: 3.536

6.  Online Care Versus In-Person Care for Improving Quality of Life in Psoriasis: A Randomized Controlled Equivalency Trial.

Authors:  April W Armstrong; Adam R Ford; Cindy J Chambers; Emanual Maverakis; Cory A Dunnick; Mary-Margaret Chren; Joel M Gelfand; Caitlin M Gibbons; Brittany M Gibbons; Christianne J Lane
Journal:  J Invest Dermatol       Date:  2018-11-24       Impact factor: 8.551

7.  Effectiveness of Online vs In-Person Care for Adults With Psoriasis: A Randomized Clinical Trial.

Authors:  April W Armstrong; Cindy J Chambers; Emanual Maverakis; Michelle Y Cheng; Cory A Dunnick; Mary-Margaret Chren; Joel M Gelfand; David J Wong; Brittany M Gibbons; Caitlin M Gibbons; Josefina Torres; Andrea C Steel; Elizabeth A Wang; Caitlin M Clark; Sanminder Singh; Heather A Kornmehl; Reason Wilken; Aleksandra G Florek; Adam R Ford; Chelsea Ma; Nazanin Ehsani-Chimeh; Sucharita Boddu; Mayumi Fujita; Paulina M Young; Cesar Rivas-Sanchez; Brenda I Cornejo; Laura C Serna; Eric R Carlson; Christianne J Lane
Journal:  JAMA Netw Open       Date:  2018-10-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.